Clinical Trial Update: Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates adjuvant gemcitabine and cisplatin followed by chemoradiation for resected pancreatic cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED